The best way forward is to generate a conditional lox-cre mouse model for DYRK2 and generate hemizygous/homozygous deletion of DYRK2 in different subtypes of breast cancer genetically engineered mouse models (GEMMs) (107). This evidence concerns the gene DYRK2 and breast cancer.